Intravenous fluids in acute decompensated heart failure

JACC: Heart Failure

Volumn 3, Issue 2, 2015, Pages 127-133

  Bikdeli, Behnood ^a,b   Strait, Kelly M ^a   Dharmarajan, Kumar ^a,c   Li, Shu Xia ^a   Mody, Purav ^a,d   Partovian, Chohreh ^b   Coca, Steven G ^b   Kim, Nancy ^a,b   Horwitz, Leora I ^a,b   Testani, Jeffrey M ^b   Krumholz, Harlan M ^a,b,e  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

Diuretics; Heart failure; HF; ICD 9 CM; Intravenous fluids

Indexed keywords

FUROSEMIDE; INFUSION FLUID; LOOP DIURETIC AGENT; SODIUM CHLORIDE; ISOTONIC SOLUTION; RINGER'S SOLUTION;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FLUID THERAPY; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE; INTUBATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY; ADOLESCENT; ENDOTRACHEAL INTUBATION; FACTUAL DATABASE; HEART FAILURE; HOSPITAL MORTALITY; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FLUID THERAPY; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; INTUBATION, INTRATRACHEAL; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; SALINE SOLUTION, HYPERTONIC; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; UNITED STATES; YOUNG ADULT;

EID: 84922012943     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.09.007     Document Type: Article

References (22)

1. Schrier R.W., Abraham W.T. Hormones and hemodynamics in heart failure. NEngl J Med 1999, 341:577-585.
2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. NEngl J Med 1991, 325:293-302. The SOLVD Investigators.
3. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. Control Clin Trials 1996, 17:77-97. Digitalis Investigators Group.
4. Issa V.S., Andrade L., Ayub-Ferreira S.M., et al. Hypertonic saline solution for prevention of renal dysfunction in patients with decompensated heart failure. Int J Cardiol 2013, 5:34-40.
5. Paterna S., Di Pasquale P., Parrinello G., et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. JAm Coll Cardiol 2005, 45:1997-2003.
6. Hunt S.A., Abraham W.T., Chin M.H., et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of theAmerican College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009, 53:e1-e90.
7. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388-2442.
8. Weintraub N.L., Collins S.P., Pang P.S., et al. Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation 2010, 122:1975-1996.
9. Hilton A.K., Pellegrino V.A., Scheinkestel C.D. Avoiding common problems associated with intravenous fluid therapy. Med J Aust 2008, 189:509-513.
10. Prowle J.R., Bellomo R. Fluid administration and the kidney. Curr Opin Crit Care 2010, 16:332-336.
11. Premier Research Services. Premier healthcare alliance. Available at: Accessed November 14,2014. http://www.premierinc.com/prs.
12. GlobalRPH. The clinician's ultimate reference. Available at: Accessed December 4, 2014. http://www.globalrph.com.
13. Peacock W.F., Costanzo M.R., De Marco T., et al. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology 2009, 113:12-19.
14. Shankar S.S., Brater D.C. Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol 2003, 284:F11-F21.
15. Mielniczuk L.M., Tsang S.W., Desai A.S., et al. Theassociation between high-dose diuretics and clinical stability in ambulatory chronic heart failurepatients. JCard Fail 2008, 14:388-393.
16. Piazza G., Goldhaber S.Z. The acutely decompensated right ventricle: pathways for diagnosis and management. Chest 2005, 128:1836-1852.
17. Licata G., Di Pasquale P., Parrinello G., et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J 2003, 145:459-466.
18. Drazner M.H., Palmer B.F. Hypertonic saline: anovel therapy for advanced heart failure?. Am Heart J 2003, 145:377-379.
19. Yeates K.E., Singer M., Morton A.R. Salt and water: a simple approach to hyponatremia. CMAJ 2004, 170:365-369.
20. Quan H., Li B., Saunders L.D., et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res 2008, 43:1424-1441.
21. Birman-Deych E., Waterman A.D., Yan Y., Nilasena D.S., Radford M.J., Gage B.F. Accuracy of ICD-9-CM codes for identifying cardiovascular andstroke risk factors. Med Care 2005, 43:480-485.
22. Kumler T., Gislason G.H., Kirk V., et al. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail 2008, 10:658-660.